Fulgent Genetics Secures $99M VA Contract For Genetic Testing

A leader in clinical molecular diagnostic testing, fulgent has been periodically providing genetic testing services to the members of the va since 2017. The new contract covers the provisions of hereditary cancer testing. Department of veterans affairs (va) to. The $99m va contract represents a significant win for fulgent genetics, potentially adding approximately $20m in annual revenue over five years. This is particularly noteworthy.

Fulgent genetics awarded contract by the u. s. Department of veterans affairs to provide hereditary cancer, pharmacogenetic and other genetic testing to veterans1. Fulgent genetics awarded contract by the u. s. Department of veterans affairs to provide hereditary cancer, pharmacogenetic and other genetic testing to veterans 1.